Harper Molly

CIK 00018714701 companyCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001871470

Recent Transactions

50 trades

Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−23,248→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2026-07-15$31.50/sh−3,694→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−12,500→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−20,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−15,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−29,524→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−5,468→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−1,894→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−1,414→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−18,115→ 0 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-29+1,334→ 3,694 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-29−1,334→ 127,163 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-12-12$23.20/sh−15,527→ 13,579 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-12-12$23.73/sh−4,473→ 9,106 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-12-12$23.06/sh−6,746→ 2,360 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-12-12−20,000→ 128,497 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-12-12$5.78/sh+20,000→ 29,106 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08+1,413→ 9,106 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-08−1,413→ 148,497 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-21−947→ 149,910 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21+947→ 7,693 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-20+18,115→ 145,389 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-20+5,468→ 150,857 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14+4,000→ 6,746 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−4,000→ 127,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27+1,333→ 2,746 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−1,333→ 131,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−1,413→ 132,607 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09+1,413→ 1,413 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-27−17,500→ 134,020 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-27$5.78/sh+17,500→ 17,500 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-27$22.00/sh−17,500→ 0 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-11-21+2,841→ 151,520 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21+23,248→ 148,679 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-06-03$16.30/sh−5,333→ 0 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-02-15−4,000→ 125,431 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-02-15+4,000→ 5,333 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27+1,333→ 1,333 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−1,333→ 129,431 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-15−10,000→ 130,764 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-15$14.37/sh−10,000→ 0 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-15$5.78/sh+10,000→ 10,000 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-15$14.43/sh−4,000→ 0 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-08+29,524→ 136,524 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-08+4,240→ 140,764 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-02-15+4,000→ 107,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-02-15+4,000→ 4,000 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-12-27+15,000→ 107,000 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-27+4,000→ 111,000 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-02-14+12,000→ 92,000 total

Companies

CATALYST PHARMACEUTICALS, INC.
Director
$CPRX

Recent Filings

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134

View on SEC.gov